Performance and Safety of Otinova® Ear Spray
Otitis ExternaThe purpose of this study is to assess the performance and safety of Otinova® Ear Spray when used in the treatment of external otitis symptoms.
18F-FDG Tomography and Labeled Leukocyte Scintigraphy
Malignant Otitis ExternaThe study will aim to show that there is a superiority of 18F-FDG PET/CT compared to labeled leukocyte scintigraphy in patients with a malignant otitis externa.
Improving Outcomes of Necrotising Otitis Externa
Necrotising Otitis ExternaA UK multi-centre prospective observational study of clinically possible cases of NOE.
Topical Voltaren in Otitis Externa
Otitis ExternaVoltaren being a Non-steroidal anti-inflammatory drug (NSAID) drug may be used as a single drug therapy in otitis externa being both therapeutic and analgesic thus reducing consumption of oral analgesia.
FST-201 In The Treatment of Acute Otitis Externa
Acute Otitis ExternaThe objective of this study is to evaluate the efficacy of FST-201 compared to Ciprodex in the treatment of acute otitis externa. This trial is designed to enable filing of a New Drug Application in support of FST-201 for the indication of acute otitis externa.
A Bioequivalence Study of Two Ciprofloxacin/Dexamethasone Formulations in Patients With Otitis Externa...
Otitis ExternaThe objective of this study is to compare the relative efficacy and safety of the test formulation of ciprofloxacin 0.3%/dexamethasone 0.1% sterile otic suspension (Par Pharmaceutical Companies, Inc.) to the already-marketed formulation CIPRODEX® (ciprofloxacin 0.3%/dexamethasone 0.1%) sterile otic suspension (Alcon) in the treatment of acute bacterial otitis externa.
FST-201 In The Treatment of Acute Fungal Otitis Externa
Acute Fungal Otitis ExternaThe objective of this study is to evaluate the efficacy of FST-201 compared to vehicle in the treatment of acute fungal otitis externa. This trial is designed to enable filing of a New Drug Application in support of FST-201 for the indication of acute fungal otitis externa.
Comparative Efficacy and Safety of Ciprofloxacin 0.3% and Dexamethasone 0.1% in Acute Otitis Externa...
Acute Otitis ExternaThe purpose of the study is to demonstrate the clinical therapeutic non-inferiority of EXL CDOS to commercially available Ciprofloxacin 0.3% and Dexamethasone 0.1% Sterile Otic Suspension (Ciprodex®, Alcon) in the treatment of acute otitis externa (AOE) when administered twice daily for 7 days.
A Phase III Study of an Otic Formulation in Acute Otitis Externa
Acute Otitis ExternaThe purpose of this study is to determine if an otic formulation is safe and effective for the treatment of acute otitis externa (AOE).
A Comparative Study Between Two Formulations of the Ciprofloxacin Hydrochloride + Hydrocortisone...
Otitis ExternaThe objective of this study is to compare the efficacy and safety profiles of the test product containing 2 mg/mL ciprofloxacin hydrochloride associated with 10 mg/mL of hydrocortisone with the reference product Cipro HC®, in patients with acute otitis externa.